PT-141 1mg / Semax 0.5mg / Oxytocin 1.5mg Blend
PT-141 1 mg / Semax 0.5 mg / Oxytocin 1.5 mg
Professional Product Render Coming Soon
PT-141 1mg / Semax 0.5mg / Oxytocin 1.5mg Blend
This blend combines PT-141, Semax, and Oxytocin, pairing melanocortin, neurotrophic, and oxytocinergic signaling in a single formulation. It supports research into convergent neuropeptide modulation of central circuits. Because the three pathways are pharmacologically independent, the formulation lets investigators test whether simultaneous engagement produces integrated effects distinguishable from any single peptide.
Volume pricing
Priced on request. Contact us for a wholesale quote.
Request a QuoteVolume pricing is based on the quantity ordered per product. Minimum order quantity: 10 units per product.
Research Overview
The rationale for this three-component formulation is convergence on central nervous system circuits through three unrelated receptor systems. PT-141 engages melanocortin receptors with activity at MC4R in hypothalamic and limbic pathways. Semax, an ACTH(4-10) analog, is associated with elevated BDNF and NGF expression and with modulation of dopaminergic and serotonergic transmission, contributing a neurotrophic and monoaminergic component. Oxytocin acts at its own Gq-coupled receptor, with central projections implicated in social behavior, affiliation, and stress reactivity. Because these three pathways are pharmacologically independent, the combination allows investigators to examine whether simultaneous engagement produces integrated neurobehavioral effects distinguishable from any single peptide. Laboratory applications include combination-versus-single-agent behavioral studies, multi-receptor signaling assays, neurotrophic factor profiling, and central neuroendocrine research.
Common Research Areas
- Behavioral neuroscience
- Melanocortin receptor pharmacology
- Neurotrophic factor research
- Oxytocin receptor pharmacology
- Combination peptide research
- Central neuroendocrine research
Key Features
- Presentation: Lyophilized vial (blend) at PT-141 1 mg / Semax 0.5 mg / Oxytocin 1.5 mg
- Category: Men's Wellness — wholesale supply only
- Minimum order quantity: 10 units per SKU
- Applied in behavioral neuroscience and melanocortin receptor pharmacology
- Cold-chain handling: store at 2–8°C, protected from light
- Research Use Only — not for human or animal consumption
Product Information
- Category
- Men's Wellness
- Format
- Lyophilized vial (blend)
- Strength
- PT-141 1 mg / Semax 0.5 mg / Oxytocin 1.5 mg
- Minimum Order Quantity
- 10 units
- Wholesale Availability
- Wholesale only
Why Researchers Choose This Product
Three pharmacologically independent pathways in one fixed-ratio vial removes the compounding preparation error of manual mixing. Laboratories testing convergent neuropeptide hypotheses need that ratio held constant across every replicate to interpret combination effects.
Storage
Store lyophilized vials refrigerated at 2–8°C. Protect from heat and light. Reconstituted material should be kept refrigerated and handled under aseptic laboratory conditions. For laboratory research use only.
Frequently Asked Questions
- What is PT-141 1mg / Semax 0.5mg / Oxytocin 1.5mg Blend studied for?
- This blend combines PT-141, Semax, and Oxytocin, pairing melanocortin, neurotrophic, and oxytocinergic signaling in a single formulation. It supports research into convergent neuropeptide modulation of central circuits. Because the three pathways are pharmacologically independent, the formulation lets investigators test whether simultaneous engagement produces integrated effects distinguishable from any single peptide.
- What research applications does PT-141 1mg / Semax 0.5mg / Oxytocin 1.5mg Blend support?
- Reported laboratory applications span behavioral neuroscience, melanocortin receptor pharmacology, neurotrophic factor research, oxytocin receptor pharmacology, combination peptide research, and central neuroendocrine research. Three pharmacologically independent pathways in one fixed-ratio vial removes the compounding preparation error of manual mixing. Laboratories testing convergent neuropeptide hypotheses need that ratio held constant across every replicate to interpret combination effects.
- What format, strength, and minimum order apply?
- PT-141 1mg / Semax 0.5mg / Oxytocin 1.5mg Blend is supplied as lyophilized vial (blend) at PT-141 1 mg / Semax 0.5 mg / Oxytocin 1.5 mg. The minimum order quantity is 10 units per SKU, and it is available to wholesale buyers only — laboratories, research organizations, distributors, and qualified commercial accounts.
- How should this product be stored and handled?
- Store lyophilized vials refrigerated at 2–8°C. Protect from heat and light. Reconstituted material should be kept refrigerated and handled under aseptic laboratory conditions. For laboratory research use only.
- Is this product suitable for human or animal use?
- No. This product is supplied strictly for laboratory and scientific research by qualified professionals. It is not for human or animal consumption, is not intended for human or veterinary use, and is not approved to diagnose, treat, cure, or prevent any disease.
Important Notice
Research Use Only. Not for human or animal consumption. These products are intended exclusively for laboratory and scientific research by qualified professionals. They are not intended for human or veterinary use and are not approved to diagnose, treat, cure, or prevent any disease.
This product is intended exclusively for laboratory research and analytical purposes. NOT FOR HUMAN CONSUMPTION. Not intended to diagnose, treat, cure, or prevent any disease.